To data, there have been 13 reported injuries. Becton Dickinson (BD)/Carefusion 303 is recalling the Alaris infusion pump due to incompatibility issues with Cardinal Health Monoject syringes. The Food ...

The U.S. FDA said that BD (NYSE:BDX) has expanded its Class I voluntary recall to inform customers about the worst-case performance of the BD Alaris Pump Module model 8100 when used with certain ...

A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...

Drug delivery devices are in the safety regulation crosshairs as of late, as a growing list of the technologies have found themselves the subject of recalls and corrections in recent weeks. Latest to ...

Dec 1 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson BDX.N is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's CAH.N ...